Connect
← Return to John Hopkins Webinar on transplant recipients and vaccines
Discussion
John Hopkins Webinar on transplant recipients and vaccines
Transplants | Last Active: Jan 13, 2022 | Replies (141)Comment receiving replies
And, Calcineurin Inhibitors, Tacrolimus and Cyclosporine, are designed to inhibit T Cells. So, we won’t be protected from those either! That leaves “Memory Cells”...so, let’s hope they have good memories!! The study also found no increase in neurological symptoms. I for one had a definite increase in neuropathy symptoms.
Replies to "And, Calcineurin Inhibitors, Tacrolimus and Cyclosporine, are designed to inhibit T Cells. So, we won’t be..."
Connect
I indicated on their survey that I developed an inflammation in my parotid gland post dose 1. Also, dizziness in the evening. I'm seeing an ENT at Mayo for this. Not fun!